Coronavirus response: Generations react differently to COVID-19
This coronavirus thing is certainly a concern,” my physician friend remarked to me.
This coronavirus thing is certainly a concern,” my physician friend remarked to me.
A quartet of studies presented at the Association for Research in Vision and Ophthalmology’s 2024 Annual Meeting addressed diverse retina-related challenges and unveiled findings with…
The investigators conducted a retrospective chart review of patients’ demographic and clinical data from 2005 to 2020.
The investigators conducted a retrospective chart review of patients’ demographic and clinical data from 2005 to 2020.
At this year’s ARVO meeting, Paolo Silva, MD, presented data on Protocol AA on behalf of the DRCR Retina Network and the effect of diabetic…
Priorities can ensure optimal outcomes for patients diagnosed with diseases.
The trial is evaluating AURN001, a combination cell therapy product comprised of neltependocel (allogeneic human corneal endothelial cells [CECs]) and Y-27632 for the treatment of…
Kamuvudine-8, also known as K8, is administered to the back of the eye via a sustained released intravitreal implant.
More companies have released information on presentations related to their pipelines and new data at the ARVO 2024 conference.
The A-IOL aims to correct both near and distance eyesight, reduce reliance on glasses or contact lenses, have no glare or halos, and restore the…
The trial is evaluating AURN001, a combination cell therapy product comprised of neltependocel (allogeneic human corneal endothelial cells [CECs]) and Y-27632 for the treatment of…